Compared side by side
Ipamorelin vs GHRP-6: how they differ
The short answer
Both release growth hormone through the ghrelin receptor: ipamorelin is the selective one, releasing GH without raising cortisol in animal studies, and GHRP-6, one of the first of the class, also raises cortisol and prolactin and strongly stimulates appetite. Both are taken 2–3 times a day. Commonly reported: intense hunger soon after a GHRP-6 dose, useful for people who want to eat more, and milder hunger on ipamorelin.
Side by side
| Compared | Ipamorelin | GHRP-6 |
|---|---|---|
| Category | Growth hormone | Growth hormone |
| Also known as | IPAM | Growth Hormone Releasing Peptide-6 |
| What it is | Considered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides. | One of the first growth hormone releasing peptides, with one standout effect: strong appetite stimulation. |
| How it works | Selective growth hormone secretagogue and ghrelin receptor agonist. In animal studies it released GH without raising cortisol or ACTH, and users report milder hunger than with GHRP-6. Considered one of the cleanest GH pulses available. | First-generation GH secretagogue that stimulates GH via ghrelin receptor activation. Significantly increases appetite (shown in animals and widely reported by users) — useful for those seeking to bulk. Also raises cortisol and prolactin moderately. |
| Commonly reported | Deeper sleep and vivid dreams first, then better recovery, skin quality and gradual body-composition changes, with milder hunger than GHRP-6. Its human data are a small GH study and phase 2 trials in surgical patients; it was never approved. | Intense hunger soon after a dose, water retention and puffiness, and a head rush or flush after injecting. Useful for people who want to eat more, but the hunger can be overwhelming for those trying to stay lean. Also raises cortisol and prolactin. |
| Studied range | Research range: 200–300 mcg, starting dose 200 mcg. Studied in research — not a recommendation. | Research range: 100–300 mcg. Studied in research — not a recommendation. |
| How often | 2–3x daily, best fasted or before bed | 2–3x daily |
| Half-life | ~2 hours (measured in healthy men, given IV) | ~20 min |
| Route | SubQ injection, IM injection | SubQ injection |
| Typical run | Commonly 8–12 weeks on, 4 weeks off to avoid receptor desensitisation. Some run longer with breaks. | 8–12 weeks. Strong appetite effect means some cycle more conservatively. |
| Evidence | Moderate: animal studies + some human data | Moderate: animal studies + some human data |
| Common side effects | Headache, flushing, nausea, water retention, numbness/tingling | Strong appetite increase, water retention, fatigue, cortisol elevation, prolactin elevation |
- Category
- IpamorelinGrowth hormone
- GHRP-6Growth hormone
- Also known as
- IpamorelinIPAM
- GHRP-6Growth Hormone Releasing Peptide-6
- What it is
- IpamorelinConsidered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides.
- GHRP-6One of the first growth hormone releasing peptides, with one standout effect: strong appetite stimulation.
- How it works
- IpamorelinSelective growth hormone secretagogue and ghrelin receptor agonist. In animal studies it released GH without raising cortisol or ACTH, and users report milder hunger than with GHRP-6. Considered one of the cleanest GH pulses available.
- GHRP-6First-generation GH secretagogue that stimulates GH via ghrelin receptor activation. Significantly increases appetite (shown in animals and widely reported by users) — useful for those seeking to bulk. Also raises cortisol and prolactin moderately.
- Commonly reported
- IpamorelinDeeper sleep and vivid dreams first, then better recovery, skin quality and gradual body-composition changes, with milder hunger than GHRP-6. Its human data are a small GH study and phase 2 trials in surgical patients; it was never approved.
- GHRP-6Intense hunger soon after a dose, water retention and puffiness, and a head rush or flush after injecting. Useful for people who want to eat more, but the hunger can be overwhelming for those trying to stay lean. Also raises cortisol and prolactin.
- Studied range
- IpamorelinResearch range: 200–300 mcg, starting dose 200 mcg. Studied in research — not a recommendation.
- GHRP-6Research range: 100–300 mcg. Studied in research — not a recommendation.
- How often
- Ipamorelin2–3x daily, best fasted or before bed
- GHRP-62–3x daily
- Half-life
- Ipamorelin~2 hours (measured in healthy men, given IV)
- GHRP-6~20 min
- Route
- IpamorelinSubQ injection, IM injection
- GHRP-6SubQ injection
- Typical run
- IpamorelinCommonly 8–12 weeks on, 4 weeks off to avoid receptor desensitisation. Some run longer with breaks.
- GHRP-68–12 weeks. Strong appetite effect means some cycle more conservatively.
- Evidence
- IpamorelinModerate: animal studies + some human data
- GHRP-6Moderate: animal studies + some human data
- Common side effects
- IpamorelinHeadache, flushing, nausea, water retention, numbness/tingling
- GHRP-6Strong appetite increase, water retention, fatigue, cortisol elevation, prolactin elevation
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
Ipamorelin
- Day 1–14 Sleep is deepening
- Day 14–28 Recovery is noticeably faster
- Day 28–56 Body composition shifts showing up
- Day 56–84 Cycle-end + planned break
GHRP-6
- Day 1–7 The hunger is real — plan for it
- Day 7–56 GH is elevated — use the appetite wisely
Questions people ask
How long do ipamorelin and GHRP-6 last?
The half-life of ipamorelin is ~2 hours (measured in healthy men, given IV). The half-life of GHRP-6 is ~20 min.
How often are ipamorelin and GHRP-6 taken?
Ipamorelin: 2–3x daily, best fasted or before bed. Routes: SubQ injection, IM injection. GHRP-6: 2–3x daily. Route: SubQ injection.
How are ipamorelin and GHRP-6 dosed in research?
The research range for ipamorelin is 200–300 mcg, with a 200 mcg starting dose. The research range for GHRP-6 is 100–300 mcg. Studied in research — not a recommendation.
What are the common side effects of ipamorelin and GHRP-6?
For ipamorelin, the library lists: headache, flushing, nausea, water retention, numbness/tingling. For GHRP-6: strong appetite increase, water retention, fatigue, cortisol elevation, prolactin elevation.